Building a better future with biologics

Published: 4-Mar-2016

UK government investment in the new National Biologics Manufacturing Centre is paving the way for a bigger future in biological treatments in the UK. Susan Birks looks at what went into the design and build of this new facility

You need to be a subscriber to read this article.
Click here to find out more.

Built as a result of the UK government’s Strategy for UK Life Sciences, which was launched in 2011 to strengthen the life-science sector, the National Biologics Manufacturing Centre is a £38m investment to help UK companies to develop a competitive foothold in the growing biologics market. The Centre for Process Innovation (CPI) was selected to develop and manage this large, open access facility that will help companies of all sizes to develop, prove, prototype and scale up the next generation of biologic products, processes and technology.

Located at Central Park, Darlington, the Biologics Centre will support the commercialisation of research by promoting collaboration between academia, the National Health Service and industry. The facility provides a well serviced, flexible laboratory and pilot plant areas for process, analytical and technology development, cleanrooms for GMP process and equipment proving and flexible, open-plan areas where new facility design concepts can be developed and tested. In addition to the technical facilities, the centre will provide training and conferencing facilities, together with office and meeting spaces.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.

Subscribe now Already a subscriber? Sign in here.

Relevant companies

You may also like